Production (Stage)
Black Bird Biotech, Inc.
BBBT
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 33.40% | 26.19% | -10.75% | -7.21% | 56.98% |
| Total Depreciation and Amortization | -31.19% | -51.92% | 14,327.27% | -95.05% | -32.32% |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | 972.88% | -200.00% |
| Total Other Non-Cash Items | 15,533.33% | -97.09% | -77.71% | -4.55% | -49.53% |
| Change in Net Operating Assets | -7.88% | 2,754.55% | -103.94% | -21.19% | 553.85% |
| Cash from Operations | 67.11% | 84.95% | 13.31% | 8.35% | 68.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -68.11% | -61.64% | -46.67% | 31.96% | -63.91% |
| Total Debt Repaid | 66.59% | 51.02% | 53.25% | -150.99% | -65.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -72.92% | -76.70% | -33.19% | -33.12% | -59.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.00% | 98.66% | -71.43% | -258.39% | 125.85% |